EXIABIO
Exia Bio opens to the public on 1 July 2026. Members who join early access now receive the founding price at checkout — S$99 for Baseline Analysis, S$249 for Deep Map.
We’ll email you your founding price checkout link before 1 July 2026. Check your inbox for a confirmation from Exia Bio.
Browse Products arrow_forwardWhat early access means
You receive a personal checkout link at S$99 (Baseline Analysis) or S$249 (Deep Map) before the standard price applies on launch.
You will receive one email before or on 1 July 2026 with your checkout link. No promotional emails beyond that without your consent.
After checkout, you receive a private link to upload your report and complete the intake questionnaire — no rush to upload immediately.
Target release within 72 hours of complete intake and usable report upload. Turnaround times depend on report completeness.
Non-diagnostic: Sentinel dashboards are for informational and educational purposes only. Exia Bio does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional for medical concerns.
Founding prices — early access members only
Tier 1 biomarker review from your uploaded report. Sentinel Efficiency Score, system resistance summary, optimization priority stack.
View product details →Expanded Tier 1 + Tier 2 biomarker interaction mapping. Deeper multi-system friction classification and pathway-specific priorities.
View product details →Pricing at launch
Dashboard comparison against your prior Sentinel baseline. Trend review across Tier 1 markers and refreshed pathway priorities.
View product details →Launch pricing applies to eligible first purchases during the launch period. Future renewals, follow-up services, and continuity plans may be priced separately unless stated otherwise.